Ben Spencer
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
[Written Question] Armed Forces Compensation Scheme and War Pensions
Question by: Dr Ben Spencer Answering Body: Ministry of Defence Question: To ask the Secretary of State for Defence, what assessment he has made of the adequacy of resourcing for War Pension and Armed Forces Compensation Scheme claim processing since the IT transition.
Passan's latest trade intel on all 30 MLB teams: B...
Major League Baseball's trade season is fast approaching, and the sport's cramped standings are providing little clarity on who's likeliest to end up where. There are too many contenders -- and too many teams whose dreams of contention remain -- to figure out how this deadline is likely to operate. At this time last year, remember, the Milwaukee Brewers, who wound up winning a major league-best 97 games, were barely above .500.
Anguished Parents, Crying Doctors: Life Amid Utah’s Measles Outbreak
Ben Dowse hadn’t expected to treat measles when he became a doctor, but there he was, examining a newborn exposed to the virus in the womb. The infected mother had given birth just hours earlier. The hospital had alerted Dowse to the case before delivery, and he’d braced himself for the worst.
Future Power Rankings: How all 68 Power 4 college football teams stack up
Projecting a college football program's future is harder than ever. Rosters and fortunes change dramatically and championship pathways are more open than ever. The assets that make a program great in 2026 might not be there in 2027.
What Aaron Judge's injury means for Yankees, the A...
Is it time to panic in the Bronx? The New York Yankees will be without three-time MVP Aaron Judge for an extended period of time after the team announced he is headed to the injured list with a right rib injury. Just how severe is the injury?
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy. Wainberg, co-director of UCLA Health’s GI Oncology Program, was leading a clinical trial of a new drug called daraxonrasib. All the study participants previously had chemotherapy that was starting to fail.